The Relationship Between Caffeine and Its Metabolites and Bone Mineral Density in Postmenopausal Women: a Cross-sectional Analysis from the NHANES Database

Overview

Journal J Nutr Sci

Publisher Cambridge University Press

Specialty Nutritional Sciences

Date 2024 Feb 28

PMID 38415243

Authors

Sheng Liao

Jianhong Zhou

Hui Chen

Wei Wei

Feng Ye

Yidong Zhang

Zhongrong Zhang

Affiliations

Soon will be listed here.

Abstract

We aim to explore the association between caffeine and its metabolites and bone mineral density (BMD) in postmenopausal women. Data of 4286 postmenopausal women were extracted from the National Health and Nutrition Examination Survey (NHANES) database in 2009-14 in this cross-sectional study. Weighted linear regression and stepwise regression analyses were used to screen the covariates. Weighted univariate and multivariate linear regression analyses were used to explore the associations between caffeine and its metabolites and BMD. The evaluation index was estimated value () with 95 % confidence intervals (CIs). We also explored these relationships in age subgroups. The median BMD level among the eligible women was 0⋅7 gm/cm. After adjusting for covariates including age, body mass index (BMI), fat intake, Calcium (Ca) supplements, diabetes mellitus (DM), angina pectoris, parental history of osteoporosis (OP), anti-osteoporosis therapy, poverty income ratio (PIR), vitamin D (VD) supplements, coronary heart disease (CHD), and previous fracture, we found that caffeine intake was not significantly related to the BMD reduction ( = 0, = 0⋅135). However, caffeine metabolites, including MethyluricAcid3, MethyluricAcid7, MethyluricAcid37, Methylxanthine3, and Methylxanthine37, were negatively associated with the BMD (all < 0⋅05). In addition, MethyluricAcid37 and Methylxanthine37 were negatively associated with BMD in females aged <65 years old, while MethyluricAcid3 and Methylxanthine3 were noteworthy in those who aged ≥65 years old. The roles of caffeine and its metabolites in BMD reduction and OP in postmenopausal women needed further exploration.

References

Jaul E, Barron J . Age-Related Diseases and Clinical and Public Health Implications for the 85 Years Old and Over Population. Front Public Health. 2018; 5:335. PMC: 5732407. DOI: 10.3389/fpubh.2017.00335. View

Wetmore C, Ichikawa L, LaCroix A, Ott S, Scholes D . Association between caffeine intake and bone mass among young women: potential effect modification by depot medroxyprogesterone acetate use. Osteoporos Int. 2007; 19(4):519-27. DOI: 10.1007/s00198-007-0473-2. View

Cappelletti S, Piacentino D, Daria P, Sani G, Aromatario M . Caffeine: cognitive and physical performance enhancer or psychoactive drug?. Curr Neuropharmacol. 2015; 13(1):71-88. PMC: 4462044. DOI: 10.2174/1570159X13666141210215655. View

Wang Q, Yu J, Zhai H, Zhao Q, Chen J, Shu L . Temporal expression of estrogen receptor alpha in rat bone marrow mesenchymal stem cells. Biochem Biophys Res Commun. 2006; 347(1):117-23. DOI: 10.1016/j.bbrc.2006.06.070. View

Choi E, Choi K, Park S, Shin D, Joh H, Cho E . The Benefit of Bone Health by Drinking Coffee among Korean Postmenopausal Women: A Cross-Sectional Analysis of the Fourth & Fifth Korea National Health and Nutrition Examination Surveys. PLoS One. 2016; 11(1):e0147762. PMC: 4729688. DOI: 10.1371/journal.pone.0147762. View

Prince R, Dick I, Beilby J, Dhaliwal S, Devine A . A cohort study of the effect of endogenous estrogen on spine fracture risk and bone structure in elderly women and an assessment of its diagnostic usefulness. Bone. 2007; 41(1):33-8. DOI: 10.1016/j.bone.2007.03.014. View

Hua R, Zou J, Ma Y, Wang X, Chen Y, Li Y . Psoralidin prevents caffeine-induced damage and abnormal differentiation of bone marrow mesenchymal stem cells via the classical estrogen receptor pathway. Ann Transl Med. 2021; 9(15):1245. PMC: 8421924. DOI: 10.21037/atm-21-3153. View

Li S, Dai Z, Wu Q . Effect of coffee intake on hip fracture: a meta-analysis of prospective cohort studies. Nutr J. 2015; 14:38. PMC: 4412140. DOI: 10.1186/s12937-015-0025-0. View

Conlisk A, Galuska D . Is caffeine associated with bone mineral density in young adult women?. Prev Med. 2000; 31(5):562-8. DOI: 10.1006/pmed.2000.0742. View

10.

Baker J, Weber D, Neogi T, George M, Long J, Helget L . Associations Between Low Serum Urate, Body Composition, and Mortality. Arthritis Rheumatol. 2022; 75(1):133-140. PMC: 10600587. DOI: 10.1002/art.42301. View

11.

Dai Z, Li Y, Quarles L, Song T, Pan W, Zhou H . Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation. Phytomedicine. 2007; 14(12):806-14. DOI: 10.1016/j.phymed.2007.04.003. View

12.

Glover F, Caudle W, Del Giudice F, Belladelli F, Mulloy E, Lawal E . The association between caffeine intake and testosterone: NHANES 2013-2014. Nutr J. 2022; 21(1):33. PMC: 9112543. DOI: 10.1186/s12937-022-00783-z. View

13.

Tabatabaei-Malazy O, Salari P, Khashayar P, Larijani B . New horizons in treatment of osteoporosis. Daru. 2017; 25(1):2. PMC: 5297185. DOI: 10.1186/s40199-017-0167-z. View

14.

Ayers C, Kansagara D, Lazur B, Fu R, Kwon A, Harrod C . Effectiveness and Safety of Treatments to Prevent Fractures in People With Low Bone Mass or Primary Osteoporosis: A Living Systematic Review and Network Meta-analysis for the American College of Physicians. Ann Intern Med. 2023; 176(2):182-195. DOI: 10.7326/M22-0684. View

15.

Rodan G, Martin T . Therapeutic approaches to bone diseases. Science. 2000; 289(5484):1508-14. DOI: 10.1126/science.289.5484.1508. View

16.

Rahman R, Usman A, Sheikh A, Baig R . Biomarkers for Impending Risk of Osteoporosis in Premenopausal Women. J Coll Physicians Surg Pak. 2021; 31(8):910-915. DOI: 10.29271/jcpsp.2021.08.910. View

17.

Williams C, Horner A, Catt K . Effects of methylxanthines on gonadotropin-induced steroidogenesis and protein synthesis in isolated testis interstitial cells. Endocr Res Commun. 1976; 3(6):343-58. DOI: 10.3109/07435807609073909. View

18.

Davis J, Ross P, Johnson N, Wasnich R . Estrogen and calcium supplement use among Japanese-American women: effects upon bone loss when used singly and in combination. Bone. 1995; 17(4):369-73. DOI: 10.1016/s8756-3282(95)00249-9. View

19.

Khalil N, Chen A, Lee M, Czerwinski S, Ebert J, DeWitt J . Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the U.S. Population in NHANES 2009-2010. Environ Health Perspect. 2015; 124(1):81-7. PMC: 4710590. DOI: 10.1289/ehp.1307909. View

20.

Rapuri P, Gallagher J, Kinyamu H, Ryschon K . Caffeine intake increases the rate of bone loss in elderly women and interacts with vitamin D receptor genotypes. Am J Clin Nutr. 2001; 74(5):694-700. DOI: 10.1093/ajcn/74.5.694. View